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Abstract 23 
Objective:  To determine whether there was an association between the coverage of booster 24 
immunisation of Diphtheria, Tetanus, acellular Pertussis and Polio (DTaP/IPV) and second Measles, 25 
Mumps and Rubella (MMR) dose by age 5 in accordance with the English national immunisation 26 
schedule by area-level socioeconomic deprivation and whether this changed between 2007/08-27 
2010/11. 28 
Design: Ecological study. 29 
Data: Routinely collected national Cover of Vaccination Evaluated Rapidly data on immunisation 30 
coverage for DTaP/IPV booster and second MMR dose by age 5 and the Index of Multiple 31 
Deprivation (IMD). 32 
Setting: Primary Care Trust (PCT) areas in England between 2007/08-2010/11.  33 
Outcome measures: Population coverage (%) of DTaP/IPV booster and second MMR immunisation 34 
by age 5. 35 
Results: Over the 4 years among the 9,457,600 children there was an increase in the mean 36 
proportion of children being immunised for  DTaP/IPV booster and second MMR across England, 37 
increasing from 79% (standard deviation (SD12%)) to 86% (SD8%) for DTaP/IPV and 75% (SD10%) to 38 
84% (SD6%) for second MMR between 2007/08-2010/11. In 2007/08 the area with lowest DTaP/IPV 39 
booster coverage was 31% compared to 54.4% in 2010/11 and for the second MMR in 2007/08 was 40 
39% compared to 64.8% in 2010/11. A weak negative correlation was observed between average 41 
IMD score and immunisation coverage for the DTaP/IPV booster which reduced but remained 42 
statistically significant over the study period (r=-0.298, p<0.001 in 2007/08 and r=-0.179, p=0.028 in 43 
2010/11). This was similar for the second MMR in 2007/08 (r=-0.225, p=0.008) and 2008/09 (r=-44 
0.216, p=0.008) but there was no statistically significant correlation in 2009/10 (r=-0.108, p=0.186) 45 
or 2010/11 (r=-0.078, p=0.343).  46 
Conclusion:  Lower immunisation coverage of DTaP/IPV booster and second MMR dose was 47 
associated with higher area-level socioeconomic deprivation, although this inequality reduced 48 
between 2007/08-2010/11 as proportions of children being immunised increased at PCT level, 49 
particularly for the most deprived areas. However, coverage is still below the World Health 50 
Organisation recommended 95% threshold for Europe.  51 
 52 
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Introduction 55 
A recent upsurge in measles in England has reignited the debate about the need for robust delivery 56 
and coverage of childhood immunisation in order to achieve the World Health Organisation (WHO) 57 
Global vaccine action plan of ш80% coverage in each district[1] and the 95% coverage 58 
recommendation for European countries[2]  in order to maintain herd immunity [1, 3, 4]. Childhood 59 
immunisations are freely available and the immunisation schedule in England incorporates boosters 60 
provided between the ages of 3 years and 4 months to 5 years for diphtheria, tetanus, acellular 61 
pertussis, polio (DTaP/IPV booster) and the second dose of measles, mumps and rubella (MMR).  62 
Coverage of booster immunisations has steadily increased for  DTaP/IPV from 78.6% in 2007/08 to 63 
87.4% in 2011/12 and second MMR from 74.6% in 2007/08 to 86.0% in 2011/12 [5]. However, 64 
evidence indicates that there remains significant variation in geographical coverage, particularly in 65 
large conurbations [6]. Several studies have shown a link between low coverage of childhood 66 
immunisations and increasing deprivation [7-19]. It has been postulated that children living in areas 67 
of high deprivation are less likely to be immunised due to the high degree of transience within such 68 
communities, higher proportions of ethnic minorities, incomplete or absent primary immunisations, 69 
poorer access to services, higher number of families with multiple children, single parent households 70 
and very young or old mothers [19-21]. However, the evidence related to different immunisations is 71 
inconsistent. Studies of coverage of HPV immunisation [22] and MMR at age 2 [23] were not 72 
associated with deprivation. The MMR at age 2 study  utilised the Index of Multiple Deprivation 73 
(IMD) and found no association with IMD nor with the area percentage of the non-white population, 74 
however, it had a strong negative association with two IMD domains that quantify barriers to 75 
adequate housing (affordability and overcrowding) and local services (road distance to services) [23].  76 
As the DTaP/IPV booster and second MMR are provided prior to children entering the education 77 
system this is a key transition point where herd immunity is of paramount importance. Therefore, 78 
we assessed whether there was an association between the coverage of childhood booster 79 
immunisations and socioeconomic deprivation in England and whether this changed over time.  80 
Methods  81 
Study design and data sources 82 
We conducted an ecological study using aggregate data for the whole population of England 83 
available at the level of Primary Care Trust (PCT). Up until March 31
st
 2013 PCTs were the principal 84 
commissioning ďŽĚŝĞƐĨŽƌƚŚĞĐŽƵŶƚƌǇ ?ƐEĂƚŝŽŶĂů,ĞĂůƚŚService (NHS), which provides universal 85 
health care free at the point of access. We used Cover of Vaccination Evaluated Rapidly (COVER) 86 
data on immunisations and IMD data on area-level socioeconomic deprivation which are freely 87 
available online, so no formal ethical approval was required. The COVER scheme was first trialled in 88 
1987 and by 1989 most areas in England were participating [24]. These data are collated quarterly 89 
and we accessed them via the Health and Social Care Information Centre of the NHS website 90 
(http://www.hscic.gov.uk/searchcatalogue?productid=9990&q=immunisation&sort=Relevance&size91 
=10&page=1#top). COVER data are available for the British financial year which runs from April 1
st
 to 92 
March 31
st
 in the subsequent year and are thus presented as 2007/08 to 2010/11 at PCT level. The 93 
study population was all 5 year old children in England whose immunisation statistics were available 94 
as percentages of coverage for the population of children covered by each PCT with the DTaP/IPV 95 
booster and second MMR as the outcome measures. In 2008/09 to 2010/11 all PCTs achieved 96 
COVER data validation criteria and in 2007/08 141 PCTs achieved this. The number of PCTs changed 97 
from 152 in 2007-2009 to 151 in 2010 due to a boundary change on 1
st
 April 2010 with the merger of 98 
North Hertfordshire with West Hertfordshire to form Hertfordshire. 99 
Socioeconomic deprivation data were accessed from the English IMD PCT summaries for 2007 100 
http://www.communities.gov.uk/documents/communities/zip/indices2007.zip [25] and 2010 101 
https://www.gov.uk/government/publications/english-indices-of-deprivation-2010 [26] . IMD are 3-102 
yearly statistical indices that provide a ranking of areas across England by their level of 103 
socioeconomic deprivation based on 7 domains: income, education, employment, health, barriers to 104 
housing and local services, environment and crime. Each domain score is ranked and exponentially 105 
transformed.  Individual domain scores are available; however, a single population-weighted 106 
average score is also generated, allowing comparison between areas based on their relative levels of 107 
deprivation. We used the IMD average scores available at PCT level as a measure of overall 108 
deprivation; IMD scores for 2007 were used to represent deprivation for the 2007/08-2009/10 109 
COVER data and the 2010 scores were used to represent deprivation for 2010/11 COVER data.  110 
Statistical analysis 111 
All downloaded data that were available in Excel spreadsheets were imported to and analysed using 112 
Stata v.11 software. We first examined the size of the child population annually and the ranking of 113 
PCTs by IMD to assess whether there had been substantial socio-demographic changes over the 114 
study period. Over the 4 year period IMD average scores were plotted and were found to be fairly 115 
normally distributed. We assessed whether using different average IMD scores from the 2 time 116 
points of IMD collection (2007 and 2010) resulted in substantial changes in the relative 117 
socioeconomic position of PCT areas by assessing the 10 most and 10 least deprived PCT areas. 118 
The percentage coverage of DTaP/IPV and second dose of MMR across PCTs was assessed for normal 119 
distribution and were found to be not normally distributed. We created scatter plots of the average 120 
IMD score against percentage coverage of the DTaP/IPV and second MMR separately to assess 121 
whether there was a linear relationship between the exposure and outcomes. PearsŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶ122 
coefficients were used to assess correlations between deprivation and the percentage coverage of 123 
each immunisation for each financial year across the study period. Finally, for each immunisation we 124 
assessed the number of PCTs that achieved district level immunisation coverage targets of >80% and 125 
>95% set by the WHO[1, 2] and whether this had changed over the study period. 126 
  127 
 128 
Results  129 
Population socio-demographics 130 
We included data from all children with available COVER and IMD data aged 5 in England over the 4-131 
year study period. As shown in table 1, the number of PCTs achieving validation criteria for COVER 132 
data increased from 141 in 2007/08 to all PCTs achieving the criteria from 2008/09 onwards. The 133 
population of children aged 5 in England changed from 2,365,400 in 2007/08 to 2,363,800 in 134 
2010/11.  In 2010/11, Hampshire PCT had the largest number of children in this age range 135 
(n=14,800) and Hartlepool had the lowest (n=1,200). When we used the 2010 IMD scores instead of 136 
2007 IMD scores only one PCT moved out of the 10 most deprived areas, whereas, there were 3 137 
changes in 10 least deprived PCTs. For both time periods Surrey was the least deprived and Heart of 138 
Birmingham was the most deprived. IMD average scores ranged from 8.1 (least deprived) to 48.3 139 
(most deprived) with a mean value of 23.7 and median value of 23.6.  140 
Table 1.  141 
Table 2 shows that between 2007/08-2010/11 there was an increase in the mean coverage of 142 
immunisations in PCTs in England; the DTaP/IPV booster by 6.7% and second MMR dose by 9.1%. 143 
Variation of coverage across PCTs indicated by the standard deviations (Table 2) reduced for both 144 
immunisations over this period. There was also a reduction in the range of coverage for DTaP/IPV 145 
from 31.0%-94.0% (2007/08) to 54.4%-96.7% (2010/11) and for MMR from 39.0%-89.0% (2007/08) 146 
to 64.8%-95.1% (2010/11) which shows that the overall increased immunisation coverage was 147 
mainly achieved by an increase in areas with previously low coverage rates. This can also be seen in 148 
Figures 1-2: scatter plots plotting PCTs annually by their IMD average scores and their vaccination 149 
coverage for DTaP/IPV (figure 1) and MMR (figure 2). They show that whilst most PCTs across all 150 
levels of deprivation had quite high booster coverage, there were some PCTs with particularly low 151 
coverage and these were more likely to have high IMD scores. This appeared to be more so for 152 
DTaP/IPV than for MMR and figures 1-2 also show the reduced variation in immunisation coverage 153 
between 2007/8 and the 2010/11 period which was mostly due to increasing coverage in those with 154 
initially low coverage rather than increases in PCTs with initially high coverage.  155 
Table 2.  156 
Figure 1.  157 
Figure 2.  158 
Table 3 shows correlation coefficients for the association of PCTs IMD scores and immunisation 159 
coverage. With increasing average IMD score there were weak negative correlations with PCTs 160 
coverage of both DTaP/IPV and second MMR, which were statistically significant across all years for 161 
DTaP/IPV boosters and in 2007/08 and 2008/09, but not the later years, for second MMR. The weak 162 
correlation between higher deprivation and lower coverage did decrease for both immunisations 163 
over the study period. 164 
Table 3.  165 
Table 4 show the number of PCTs across the study period that achieved 95% and 80% coverage 166 
WHO targets. Over the 4 year period the number of PCTs achieving ш ? ?йĐŽǀĞƌĂŐĞ substantially 167 
increased however the percentage ƌĞĂĐŚŝŶŐш ? ?йŚĂƐƌĞŵĂŝŶĞĚďĞůŽǁ ?йĨŽƌDTaP/IPV and below 168 
1% for MMR. 169 
Table 4.  170 
Discussion 171 
Results from this ecological study demonstrate a weak statistically significant association between 172 
coverage of the DTaP/IPV booster at age 5 and deprivation over the 4 year period. Coverage for 173 
second MMR also demonstrated a weak negative correlation with deprivation however, this was 174 
only statistically significant for the periods 2007/08 and 2008/09. Over the time period there was an 175 
increase in coverage and a reduction in variation of coverage of DTaP/IPV and second MMR 176 
immunisations across PCTs in England.  The reduction in variation of coverage  in 2007/08, the 177 
lowest being 31% for DTaP/IPV and 39% for MMR and thereafter in 2010/11 being 54.4% and 64.8% 178 
respectively was particularly important as areas with low booster coverage were areas that were 179 
more deprived. Therefore, this study demonstrates that in a 4 year period areas with traditionally 180 
low immunisation coverage can improve. 181 
The strengths of this study are that a large validated national immunisation dataset was used along 182 
with nationally derived deprivation indices. The immunisation coverage and denominator data for 183 
COVER data are validated both at local and national level. Validation criteria are utilised to ensure 184 
that the number of children immunised reflects both those children registered with general practice 185 
and those who are the responsibility of the PCT [27], therefore ensuring that information is 186 
complete.  These immunisations have also been incorporated into contractual targets and therefore, 187 
active tracking of immunisation status via PCTs also supports the accuracy of these data systems. To 188 
date most research has primarily focused on primary immunisations and therefore this study 189 
provides insight into the association between coverage of boosters by the age of 5 and deprivation.  190 
As this is an ecological study we must acknowledge limitations of this method. We did not have 191 
measurements of socioeconomic deprivation for individual children nor did we know their individual 192 
ǀĂĐĐŝŶĞĐŽǀĞƌĂŐĞ ?ƐŽǁĞĐĂŶŶŽƚŵĂŬĞĂŶǇĐŽŶĐůƵƐŝŽŶƐĂƐƚŽŚŽǁĐŚŝůĚƌĞŶ ?ƐŽƌĨĂŵŝůŝĞƐ ?193 
socioeconomic circumstances may directly affect their vaccine coverage. Furthermore, within PCTs 194 
there can be considerable variation in deprivation between smaller constituent areas, so even at an 195 
ĞĐŽůŽŐŝĐĂůůĞǀĞůŽƵƌƵƐĞŽĨWdƐ ?ĂǀĞƌĂŐĞ/DŵĂǇŚĂǀĞƵŶĚĞƌĞƐƚŝŵĂƚĞĚƚŚĞĂƐƐŽĐŝĂƚŝŽŶďĞƚǁĞĞŶ196 
deprivation and low immunisation coverage. This was a necessity however, as vaccination coverage 197 
data is available only at PCT level and this enabled us to assess the COVER recorded aged 5 198 
population of England. That we have shown a persistence of socioeconomic inequality in 199 
immunisation coverage at a national level is important for the organisation of these public services.  200 
Changes in the ranking of PCTs in the IMD may have also impacted on our results as only 66% of 201 
areas remained within the same deciles of IMD in 2010/11 as in 2007/08 [28]; as this minor re-202 
classification will be for reasons other than our outcome, if anything this will have led us to 203 
underestimate the association between deprivation and low immunisation coverage.  204 
Whilst the coverage data are not normally distributed, we decided to use the mean coverage rather 205 
than median coverage as the figures were only slightly different (the median coverage was between 206 
0.6-4% higher than the mean coverage). Mean figures are standardly reported in populations so we 207 
wanted to ensure that this was comparable in the context of other research which may also 208 
interpret data that is not normally distributed. 209 
Whilst our study shows improved coverage of DTaP/IPV and second MMR at age 5 in England  we 210 
have yet to achieve targets set by the World Health Organisation in every geographical district with 4 211 
doses of DTaP/IPV and the second dose of MMR [1, 2] to support the achievement of herd 212 
immunity. By 2010/11 for DTaP/IPV booster 82.8% and for second MMR 81.5% of PCTs were 213 
achieving coverage of ш80%. Our study ascertained that by 2010/11 the European WHO 214 
recommended threshold of 95% coverage for childhood immunisations was achieved by only 2.7% of 215 
PCTs for the DTaP/IPV booster and 0.7% of PCTs achieved this for MMR. Therefore, the majority of 216 
areas still fell well below the WHO European recommended targets. In comparison coverage of 217 
primary immunisations in 2011/12 in England was higher and almost achieved targets for DTaP/IPV 218 
at 94.7% and MMR 91.2% [5] therefore we hypothesise that greater emphasis needs to be placed on 219 
clear and consistent messaging about the need for completion of booster immunisations.   Whilst 220 
there have been, now discredited, concerns over the safety of the MMR immunisation a survey of 221 
mothers in Birmingham indicated that they question the importance of the second dose of MMR[29] 222 
which may also impact on coverage. Booster doses may also be missed  by particular vulnerable 223 
groups such as children in care, children with disabilities, some minority groups and non-English 224 
speakers [30].  225 
Whilst an association between deprivation and MMR at age 2 [23]and HPV [22] immunisations were 226 
not found, other studies on immunisation coverage have been linked to deprivation in both England 227 
and New Zealand (2006) demonstrating higher coverage in more affluent populations [9, 17, 31, 32]. 228 
However, there are some notable differences between these studies and our own. Whilst the studies 229 
in England used national coverage data the time periods included when the controversy surrounding 230 
the safety of MMR was at its height in England and therefore may have affected the results. The 231 
study in New Zealand accessed coverage data for children up to 23 months old via an audit of 232 
primary care notes for an area that only covered 50% of the population and was dependant on 233 
practice agreement to the audit, which may have resulted in information bias. None of these studies 234 
assessed booster immunisations prior to entering school and therefore, our research contributes to 235 
the understanding of these immunisations. Overall we found an increase in the coverage of 236 
immunisation boosters over the 4 year period and the association between immunisation coverage 237 
and deprivation was less pronounced in the latter period of the study this is in contrast to the 238 
studies carried out prior to this one.  239 
In accordance with the World Health Organisation Global Vaccine Action Plan the Department of 240 
Health in England has adopted policies to improve immunisation coverage. Our findings have 241 
demonstrated that over the 4 year period there has been an improvement in the numbers of PCTs 242 
reporting validated results into the COVER system and this improvement in reporting provides an 243 
increasingly accurate picture of immunisation delivery. Policies have also included contractual 244 
targets with primary care for the achievement of specified immunisation performance levels as an 245 
incentive to reduce health inequalities. Whilst targets can be criticised this study indicates that they 246 
may have had a beneficial effect in increasing coverage over time. This has been supported by 247 
increased efforts of primary care to support the delivery of booster immunisation services along 248 
with active management and follow up of the children in accordance with national guidance[30] 249 
which may explain the increase in coverage.  Therefore, an integrated approach to immunisation 250 
delivery that incorporates the systematic improvement of data management, along with 251 
comprehensive and adaptable service delivery of immunisation schedules may support the 252 
reduction of inequalities. 253 
Conclusion 254 
Overall we found a weak negative correlation between WdƐ ?IMD average score and booster 255 
immunisation coverage for DTaP/IPV and the second dose of MMR, reflecting that higher area-level 256 
deprivation is associated with lower coverage.  It is important to note that whilst this inequality 257 
reduced between 2007/8 and 2010/11 for both immunisations, it still persisted for DTaP/IPV in 258 
2010/11. This improvement in coverage is indicative of the value of clear immunisation policies in 259 
supporting the reduction of health inequalities. Nevertheless, many PCTs were still not achieving 260 
targets set out the WHO so much more support is needed to improve coverage of booster 261 
immunisations.  262 
 263 
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